First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (D4194R00005)

Markman, Ben (Primary Chief Investigator (PCI))
Baker, Emma (Project Manager)

Hudson Institute - Centre for Cancer Research

Project: Research

Acronym	PACIFIC-Real World
Status	Finished
Effective start/end date	17/10/19 → 31/12/24

Keywords

Medical Oncology